Search For "astrazeneca"
Production of AstraZeneca COVID-19 vaccine begins in Australia
Updated : 5 years, 4 months ago IST
Canberra [Australia], November 9 (ANI/Sputnik): The CSL Limited company started production of the University of Oxford/AstraZeneca coronavirus vaccine on Monday, Australian media report.
Read More
AstraZeneca misses target for delivery of COVID-19 vaccine: UK Government
Updated : 5 years, 4 months ago IST
London [UK], November 5 (ANI/Sputnik): The pharmaceutical giant AstraZeneca has missed its target of delivering 30 million doses of its vaccine against COVID-19 to the UK by September, as the producer is predicted to only hand over 4 million doses by the end of the year, Kate Bingham, the he
Read More
AstraZeneca resumes US COVID-19 vaccine trial
Updated : 5 years, 5 months ago IST
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
Read More
Brazil's COVID-19 vaccine volunteer dies, authorities say trial to cont
Updated : 5 years, 5 months ago IST
Brasilia [Brazil], October 22 (ANI): A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue.
Read More
Trudeau announces vaccine pact as Canada surpasses 150,000 Covid cases
Updated : 5 years, 6 months ago IST
Toronto [Canada], September 26 (ANI/Sputnik): Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Updated : 5 years, 6 months ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More
DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19
Updated : 5 years, 6 months ago IST
New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSM
Read More
Equity indices trade higher, IT stocks shine
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 14 (ANI): Equity benchmark indices traded firm during early hours on Monday on the back of positive global cues as hopes of a coronavirus vaccine were rekindled after AstraZeneca resumed its phase three trial.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy of approa
Updated : 5 years, 6 months ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More
Serum Institute to resume COVID-19 vaccine trials in India after DCGI nod
Updated : 5 years, 6 months ago IST
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
Read More
Oxford vaccine phase 3 trials resume after halt over safety concerns
Updated : 5 years, 6 months ago IST
London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
Read More
AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite
Updated : 5 years, 6 months ago IST
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Read More